Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This Response to Comments document indicates that the public comment period for Implantable Continuous Glucose Monitors (I-CGM), document DL38686, ran from September 28, 2023 to November 11, 2023. All submitted comments during that period were reviewed, similar topics were aggregated, and responses were prepared; the document does not specify coverage criteria or changes to coverage policy.

"Public comment period for Implantable Continuous Glucose Monitors (I-CGM), document DL38686, was open from 2023-09-28 to 2023-11-11 and all comments received within this period were reviewed and ag..."

Sign up to see full coverage criteria, indications, and limitations.